Cyclin D1 Antibody
货号:
2922S 基本售价:
3360.0 元 规格:
-
产品信息
概述货号 | 2922S |
反应种属 | Human/Mouse/Rat |
来源宿主 | Rabbit |
应用 | W/IP |
使用方法 | WB(1:1000) IP (1:100) |
性能供应商 | CST |
背景 | Activity of the cyclin-dependent kinases CDK4 and CDK6 is regulated by T-loop phosphorylation, by the abundance of their cyclin partners (the D-type cyclins), and by association with CDK inhibitors of the Cip/Kip or INK family of proteins (1). The inactive ternary complex of cyclin D/CDK4 and p27 Kip1 requires extracellular mitogenic stimuli for the release and degradation of p27 concomitant with a rise in cyclin D levels to effect progression through the restriction point and pRb-dependent entry into S-phase (2). The active complex of cyclin D/CDK4 targets the retinoblastoma protein for phosphorylation, allowing the release of E2F transcription factors that activate G1/S-phase gene expression (3). Levels of cyclin D protein drop upon withdrawal of growth factors through downregulation of its protein expression and through phosphorylation-dependent degradation (4).细胞周期蛋白依赖性蛋白激酶CDK4和CDK6的活性受三个因素的调控:T-环路磷酸化,周期蛋白伴侣(D-型周期蛋白)的丰度,与CDK抑制剂Cip/Kip 或 INK蛋白家族的关系(1)。失活的三元复合物cyclin D/CDK4 和p27 Kip1需要胞外有丝分裂刺激因子参与p27伴侣的释放和降解,伴随周期蛋白D的水平升高,通过限制点和pRb依赖性的S期进入影响细胞周期的进程(2)。活跃的cyclin D/CDK4复合体靶向视网膜母细胞瘤蛋白以利于磷酸化,促进可以激活G1/S期基因表达的转录因子E2F的释放(3)。生长因子退出后,通过下调蛋白表达和磷酸化依赖性蛋白降解,周期蛋白D的水平下降(4)。 |
存放说明 | -20C |
计算分子量 | 36 |
参考图片Western blot analysis of extracts from C6 and L929 cells, using Cyclin D1 Antibody.western blot 方法检测C6和L929细胞提取物,使用的抗体为Cyclin D1 Antibody。 |